Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol

INTRODUCTION: Although neoadjuvant treatment is recommended for patients with borderline resectable pancreatic cancer (BRPC), no standard neoadjuvant regimen has been established for BRPC with arterial involvement (BRPC-A), which is associated with a higher risk of margin-positive resection and poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyasaka, Yoshihiro, Ohtsuka, Takao, Eguchi, Susumu, Inomata, Masafumi, Nishihara, Kazuyoshi, Shinchi, Hiroyuki, Okuda, Koji, Baba, Hideo, Nagano, Hiroaki, Ueki, Toshiharu, Noshiro, Hirokazu, Nakamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IJS Publishing Group 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114838/
https://www.ncbi.nlm.nih.gov/pubmed/34013145
http://dx.doi.org/10.29337/ijsp.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114838/
https://www.ncbi.nlm.nih.gov/pubmed/34013145
http://dx.doi.org/10.29337/ijsp.142

Ejemplares similares